Log In
Print this Print this

baricitinib (LY3009104) (formerly INCB28050)

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionJanus kinase-1 (JAK-1) and JAK-2 inhibitor
Molecular Target Janus kinase-2 (JAK-2) ; Janus kinase-1 (JAK-1)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor; Janus kinase-1 (JAK-1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today